miR-192 Regulates dihydrofolate reductase and cellular proliferation through the p53-microRNA circuit.
miR-192 Regulates dihydrofolate reductase and cellular proliferation through the p53-microRNA circuit.
复制标题
DOI:
10.1158/1078-0432.ccr-08-1422
复制
发表时间:
2008-12-15
期刊:
影响因子:
--
通讯作者:
Ju J
中科院分区:
文献类型:
--
作者:
Song B;Wang Y;Kudo K;Gavin EJ;Xi Y;Ju J
The purpose of this study is to investigate the molecular mechanism of miR-192 in colon cancer. Human colon cancer cell lines with different p53 status were used as our model system to study the impact of miR-192 on cell proliferation, cell cycle control and mechanism of regulation. Our results show that one of the key miR-192 target genes is dihydrofolate reductase (DHFR). miR-192 impacts cellular proliferation through the p53-miRNA circuit. Western immunoblot analyses indicated that the expression of DHFR was significantly decreased by miR-192. Further investigation revealed that such suppression was due to translational arrest rather than mRNA degradation. More profound inhibition of cellular proliferation was observed by ectopic expression of miR-192 in colon cancer cell lines containing wild type p53 than cells containing mutant p53. Thus, the effect of miR-192 on cellular proliferation is mainly p53 dependent. Over-expression of miR-192 triggered both G1 and G2 arrest in HCT-116 (wt-p53) cells but not in HCT-116 (null-p53) cells. The cell cycle check point control genes p53 and p21 were highly over-expressed in cells that over-expressed miR-192. Endogenous miR-192 expression was increased in HCT-116 (wt-p53) and RKO (wt-p53) cells treated with methotrexate, which caused an induction of p53 expression. Chromatin immunoprecipitation (ChIP)-qPCR analysis revealed that the p53 protein interacted with the miR-192 promoter sequence. These results indicate that miR-192 may be another miRNA candidate that is involved in the p53 tumor suppressor network with significant impact on cell cycle control and cell proliferation.